Heron Therapeutics
HRTX
HRTX
190 hedge funds and large institutions have $1.33B invested in Heron Therapeutics in 2020 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 69 increasing their positions, 53 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 193 → 190 (-3)
4.92% less ownership
Funds ownership: 102.69% → 97.77% (-4.9%)
19% less call options, than puts
Call options by funds: $5.02M | Put options by funds: $6.17M
Holders
190
Holding in Top 10
4
Calls
$5.02M
Puts
$6.17M
Top Buyers
| 1 | +$22M | |
| 2 | +$10.8M | |
| 3 | +$10.1M | |
| 4 |
BlackRock
New York
|
+$9.82M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$8.51M |
Top Sellers
| 1 | -$36.6M | |
| 2 | -$16.2M | |
| 3 | -$15.3M | |
| 4 |
Renaissance Technologies
New York
|
-$11.9M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$10.7M |